Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
or

Inmed Pharmaceuticals Inc (INM)

Inmed Pharmaceuticals Inc (INM)
4.31 -0.20 (-4.43%) 01/10/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Quote Overview for Fri, Jan 10th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
4.26
Day High
4.73
Open 4.59
Previous Close 4.51 4.51
Volume 52,800 52,800
Avg Vol 23,150 23,150
Stochastic %K 25.64% 25.64%
Weighted Alpha -73.36 -73.36
5-Day Change -0.49 (-10.21%) -0.49 (-10.21%)
52-Week Range 2.41 - 15.70 2.41 - 15.70
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,266
  • Shares Outstanding, K 724
  • Annual Sales, $ 4,600 K
  • Annual Income, $ -7,680 K
  • EBIT $ -7 M
  • EBITDA $ -7 M
  • 60-Month Beta 0.23
  • Price/Sales 0.75
  • Price/Cash Flow N/A
  • Price/Book 0.36

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.11 +4.86%
on 01/08/25
Period Open: 5.11
5.41 -20.33%
on 01/06/25
-0.80 (-15.66%)
since 12/10/24
3-Month
3.65 +18.08%
on 11/18/24
Period Open: 4.20
7.16 -39.80%
on 10/25/24
+0.11 (+2.62%)
since 10/10/24
52-Week
2.41 +78.54%
on 08/06/24
Period Open: 8.18
15.70 -72.54%
on 08/20/24
-3.87 (-47.31%)
since 01/10/24

Most Recent Stories

More News
InMed Announces Results of 2024 Annual General Meeting

Vancouver, British Columbia--(Newsfile Corp. - December 18, 2024) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary...

INM : 4.31 (-4.43%)
InMed Enters Into Standby Equity Purchase Agreement

Vancouver, British Columbia--(Newsfile Corp. - December 17, 2024) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary...

INM : 4.31 (-4.43%)
InMed Announces Publication of Study on Anti-Inflammation by Modulation of Endocannabinoid System

Cannabinol modulates distinct endocannabinoid system elements and exerts anti-inflammatory effectsSupports therapeutic potential of cannabinol for inflammatory skin diseases such as psoriasis, atopic dermatitis...

INM : 4.31 (-4.43%)
InMed Reports First Quarter Fiscal 2025 Financial Results and Provides Business Update

Vancouver, British Columbia--(Newsfile Corp. - November 14, 2024) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary...

INM : 4.31 (-4.43%)
InMed Announces Share Consolidation to Satisfy Nasdaq Listing Rules

Vancouver, British Columbia--(Newsfile Corp. - November 8, 2024) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary...

INM : 4.31 (-4.43%)
InMed Pharmaceuticals Announces Decision by NASDAQ Hearings Panel to Grant Exception to Implement Share Consolidation to Satisfy NASDAQ Listing Rules

Vancouver, British Columbia--(Newsfile Corp. - November 5, 2024) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary...

INM : 4.31 (-4.43%)
InMed Pharmaceuticals Files Additional Patent Application for INM-901 in the Treatment of Neurodegenerative Conditions Including Alzheimer's Disease

Vancouver, British Columbia--(Newsfile Corp. - October 28, 2024) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary...

INM : 4.31 (-4.43%)
InMed to Participate in Fierce Biotech Webinar on Neuroinflammation in Alzheimer's Disease

Vancouver, British Columbia--(Newsfile Corp. - October 24, 2024) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary...

INM : 4.31 (-4.43%)
InMed Appoints Dr. Barry Greenberg, Johns Hopkins University School of Medicine, to its Scientific Advisory Board

Vancouver, British Columbia--(Newsfile Corp. - October 22, 2024) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary...

INM : 4.31 (-4.43%)
InMed Pharmaceuticals Reports Full Year Fiscal 2024 Financial Results and Provides Business Update

Advances INM-901 program targeting several biological pathways associated with Alzheimer's diseaseFurther develops INM-089 demonstrating neuroprotection in the treatment of dry Age-related Macular Degeneration$4.6M...

INM : 4.31 (-4.43%)

Business Summary

InMed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. It engages in developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol in diseases with unmet medical need. InMed Pharmaceuticals Inc. is based in VANCOUVER, BC.

See More

Key Turning Points

3rd Resistance Point 5.08
2nd Resistance Point 4.90
1st Resistance Point 4.61
Last Price 4.31
1st Support Level 4.14
2nd Support Level 3.96
3rd Support Level 3.67

See More

52-Week High 15.70
Fibonacci 61.8% 10.62
Fibonacci 50% 9.06
Fibonacci 38.2% 7.49
Last Price 4.31
52-Week Low 2.41

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Trading Volume: The most powerful technical indicator in the world